Enovis Corporation ENOV
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-11T15:53:41.567Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:53:27.089489452Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T15:53:40.947009+00:00
Enovis Corporation options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 32.77 | 85.5% | 17.2% | 23.88 | 145.9% | 18.7% |
| 25Δ | 31.88 | 84.6% | 14.5% | 24.88 | 146.8% | 16.1% |
| 30Δ | 30.98 | 83.7% | 11.8% | 25.55 | 139.3% | 14.3% |
| 35Δ | 30.09 | 82.8% | 9.1% | 26.18 | 130.7% | 12.7% |
| 40Δ | 29.52 | 84.0% | 8.2% | 26.80 | 122.1% | 11.0% |
| 45Δ | 28.98 | 85.5% | 7.4% | 27.43 | 113.5% | 9.4% |
| 50Δ | 28.43 | 87.0% | 6.6% | 28.05 | 104.9% | 7.7% |
| 55Δ | 27.89 | 88.4% | 5.8% | 28.68 | 96.3% | 6.0% |
| 60Δ | 27.35 | 89.9% | 5.1% | 29.30 | 87.7% | 4.4% |
| 65Δ | 26.81 | 91.3% | 4.3% | 29.93 | 79.1% | 2.7% |
| 70Δ | 26.27 | 92.8% | 3.5% | 31.11 | 86.6% | 2.2% |
| 75Δ | 25.73 | 94.3% | 2.7% | 32.35 | 96.1% | 1.9% |
| 80Δ | 25.19 | 95.7% | 2.0% | 33.60 | 105.7% | 1.5% |
20Δ
- Pseudo strike
- 32.77
- IV
- 85.5%
- B/E move
- 17.2%
- Pseudo strike
- 23.88
- IV
- 145.9%
- B/E move
- 18.7%
25Δ
- Pseudo strike
- 31.88
- IV
- 84.6%
- B/E move
- 14.5%
- Pseudo strike
- 24.88
- IV
- 146.8%
- B/E move
- 16.1%
30Δ
- Pseudo strike
- 30.98
- IV
- 83.7%
- B/E move
- 11.8%
- Pseudo strike
- 25.55
- IV
- 139.3%
- B/E move
- 14.3%
35Δ
- Pseudo strike
- 30.09
- IV
- 82.8%
- B/E move
- 9.1%
- Pseudo strike
- 26.18
- IV
- 130.7%
- B/E move
- 12.7%
40Δ
- Pseudo strike
- 29.52
- IV
- 84.0%
- B/E move
- 8.2%
- Pseudo strike
- 26.80
- IV
- 122.1%
- B/E move
- 11.0%
45Δ
- Pseudo strike
- 28.98
- IV
- 85.5%
- B/E move
- 7.4%
- Pseudo strike
- 27.43
- IV
- 113.5%
- B/E move
- 9.4%
50Δ
- Pseudo strike
- 28.43
- IV
- 87.0%
- B/E move
- 6.6%
- Pseudo strike
- 28.05
- IV
- 104.9%
- B/E move
- 7.7%
55Δ
- Pseudo strike
- 27.89
- IV
- 88.4%
- B/E move
- 5.8%
- Pseudo strike
- 28.68
- IV
- 96.3%
- B/E move
- 6.0%
60Δ
- Pseudo strike
- 27.35
- IV
- 89.9%
- B/E move
- 5.1%
- Pseudo strike
- 29.30
- IV
- 87.7%
- B/E move
- 4.4%
65Δ
- Pseudo strike
- 26.81
- IV
- 91.3%
- B/E move
- 4.3%
- Pseudo strike
- 29.93
- IV
- 79.1%
- B/E move
- 2.7%
70Δ
- Pseudo strike
- 26.27
- IV
- 92.8%
- B/E move
- 3.5%
- Pseudo strike
- 31.11
- IV
- 86.6%
- B/E move
- 2.2%
75Δ
- Pseudo strike
- 25.73
- IV
- 94.3%
- B/E move
- 2.7%
- Pseudo strike
- 32.35
- IV
- 96.1%
- B/E move
- 1.9%
80Δ
- Pseudo strike
- 25.19
- IV
- 95.7%
- B/E move
- 2.0%
- Pseudo strike
- 33.60
- IV
- 105.7%
- B/E move
- 1.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 75.28% | |
| 67.10% | |
| 63.76% | |
| 64.23% | |
| 60.62% | |
| 68.81% | |
| 59.33% | |
| 61.21% | |
| 66.34% | |
| 71.53% | |
| 73.29% | |
| 73.23% | |
| 80.26% | |
| 77.72% | |
| 105.41% | |
| 76.24% | |
| 74.02% | |
| 78.41% | |
| 70.01% | |
| 74.15% | |
| 67.43% | |
| 78.20% | |
| 69.47% | |
| 68.33% | |
| 71.69% | |
| 75.02% | |
| 73.65% | |
| 76.33% | |
| 81.88% | |
| 113.11% | |
| 71.98% | |
| 69.19% | |
| 69.76% | |
| 72.83% | |
| 72.30% | |
| 76.77% | |
| 76.84% | |
| 75.42% | |
| 78.07% | |
| 73.31% | |
| 83.07% |
Medical Devices
ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for cosmetic and reconstructive plastic surgery. The company is…
More →EW
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
More →GEHC
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago,…
More →GKOS
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and…
More →GMED
Description unavailable
More →HAE
Description unavailable
More →